medicare-drug-negotiation
3 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 25A519 | Bristol Myers Squibb Company v. Robert F. Kennedy, Secretary of Health and Human Services, et al. | Third Circuit | 2025-11-05 | Application | constitutional-challenge drug-pricing fifth-amendment first-amendment inflation-reduction-act medicare-drug-negotiation | Whether the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act of 2022 violates the Fifth and First Amendments | |
| 25A514 | Janssen Pharmaceuticals, Inc. v. Robert F. Kennedy, Secretary of Health and Human Services, et al. | Third Circuit | 2025-11-04 | Application | compelled-speech fifth-amendment first-amendment government-coercion medicare-drug-negotiation takings-clause | Whether the Medicare Drug Price Negotiation Program's mandatory price negotiations and severe financial penalties for non-compliance constitute an unc… | |
| 25A357 | Boehringer Ingelheim Pharmaceuticals, Inc. v. Department of Health and Human Services, et al. | Second Circuit | 2025-09-29 | Presumed Complete | compelled-speech fifth-amendment first-amendment medicare-drug-negotiation price-setting takings-clause | Whether the Medicare Drug Price Negotiation Program's compulsory participation and price-setting mechanism constitutes an unconstitutional taking or c… |